v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Sep. 30, 2025
Current assets:    
Cash and cash equivalents $ 34,928 $ 32,298
Short-term marketable securities 128,846 156,566
Accounts receivable 7,809 6,882
Prepaid expenses and other current assets 6,810 8,590
Income tax receivable 19 0
Total current assets 178,412 204,336
Long-term marketable securities 63,238 0
Property and equipment, net 33,114 35,395
Operating lease, right-of-use assets 36,436 37,549
Long-term restricted cash 3,360 3,360
Other long-term assets 144 92
Total assets 314,704 280,732
Current liabilities:    
Accounts payable 4,363 1,948
Accrued expenses and other current liabilities 6,859 12,751
Liability related to the sale of future royalties 31,461 30,710
Operating lease liabilities 3,759 3,146
Total current liabilities 46,442 48,555
Liability related to the sale of future royalties, net of current portion 97,309 111,132
Operating lease liabilities, net of current portion 52,777 54,757
Series 1 nonconvertible preferred stock 1,311 1,311
Other long-term liabilities 278 260
Total liabilities 198,117 216,015
Commitments and contingencies (Note 10)
Stockholders' equity:    
Common stock; $0.01 par value per share, 100,000 shares authorized; 29,061 and 21,387 shares issued and outstanding at March 31, 2026 and September 30, 2025 respectively 291 214
Additional paid-in capital 546,988 469,771
Accumulated other comprehensive loss (734) (339)
Accumulated deficit (429,958) (404,929)
Total stockholders' equity 116,587 64,717
Total liabilities and stockholders' equity $ 314,704 $ 280,732